Yintoni iAkathisia?

Into Omele Uyazi Ukuba Imithi Yakho ye-Bipolar Iyabangela Ukungahlali

I-Akathisia, kunye ne-spelled acathisia, i-neuropsychiatric syndrome okanye i-disorder disorder ebonakaliswa ukungazinzi kwangaphakathi kunye nokungakwazi ukuhlala okanye ukuma ixesha elifanelekileyo. I-Akathisia ingabonakala njengempembelelo yecala lokusetyenziswa kwexesha elide lweyeza-antipsychotic , iLithium , kunye nezinye iziyobisi ze-neuroleptic. Ngenye yezona ziphumo eziqhelekileyo eziqhelekileyo zemithi ye-antipsychotic, kodwa kunokuba kunzima ukuchaza ngezigulane kwaye kunzima ukuxilonga oogqirha.

Xa i-akathisia ibangelwa yimichiza, iyaziwa ngokuba yi-antipsychotic-induced acute akathisia (AIAA). Ngenxa yokuba kuyaziwa ukuba isizathu senzeke ngenxa yokunyangwa kwengxaki yengqondo, ukukhusela i-akathisia kubalulekile, ngelixa ukuphuma kweyeza lakho akucebisi okanye kuyindlela efanelekileyo yokuphatha i-akathisia. Apha sinazo iindlela onokuyinqoba ngayo i-akathisia ngaphandle kokuphazamisa impilo kunye nenhlalakahle yakho ngexesha uthabatha iziyobisi zengqondo.

Ubuninzi beAkathisia

Phakathi ko-20 no-45% wabantu abathatha amayeza okulwa ne-antipsychotic ama-akathisia. I-Barnes Akathisia-Rating Scale isetyenziselwa ukuxilonga imeko. Ukuba uhlala e-akathisia, unakho ukuhamba okungazinziyo kwezandla kunye nemilenze efana nokubetha, ukuhamba endaweni, ukugubha, ukuwela kunye nokugqithisa imilenze. Ngamanye amaxesha kuthethwa ngokuba ngu- p sychomotor agitation .

Umzimba wakho unokuziva uxhalabile ngcamango yokuhlala phantsi. Umzimba wakho uya kuhlala ufuna ukuhamba, phantse ukuya kwinqanaba lokutshixa xa kusetyenziswe iseshingi.

Kukho iintlobo ezine zeengxaki zokunyakaza ezinxulumene nezidakamizwa zokulwa ne-antipsychotic. Maxa wambi i-akathisia inokudibaniswa kunye nale miqobo yokunyakaza, okanye ingaba yodwa kuphela:

Iimbangela ze-antipsychotic-eyenziwa yiAkathisia

U-Akathisia ngokuqhelekileyo uyaphononongwa okanye akafumani kakuhle.

Ukwanda koxilongo olungekho phantsi kwimeko enobungozi njengoko kunokukhokelela kwimiphumo emibi njengamachiza amayeza angaphoswanga, anokuthi unyuse iimpawu zeengqondo ezibhekiselele ekuncedeni ukulawula.

Ngenxa yokuba le meko ibangelwa yimichiza yonyango, kubalulekile ukuba uqaphele izifundo ezichaze izidakamizwa ezithile ezichaphazelekayo ezibangelwa ingozi ephezulu ye-akathisia. I-Haloperidol, i-paliperidone, kunye ne-ziprasidone baye babonwa ukuba bandise umngcipheko we-akathisia kwizigulane ezithatha leziyobisi. Nangona ezi zikhethiweyo, kubalulekile ukuqaphela ukuba zonke izidakamizwa zokulwa nezidakamizwa zithwala ingozi yokubangela i-akathisia.

Ngelishwa, nje ngokuba uqala unyango lwe-antipsychotic lungabangela i-akathisia, kubonakala nakwabantu abaye bathatyathwa ngokunyanisekileyo kwiyeza zabo zokulwa ne-antipsychotic okanye ngubani onokucetyiswa ukuba anciphise kancane amanani abo. Kule meko, i-dysphoria enkulu idlalwa njalo.

Unyango lweAkathisia

Injongo yonyango ye-akathisia ngokuqhelekileyo ukukhuthaza ukuzola, ngaphandle kokuhlala phezulu. Uphononongo kwiphepha le-Drug Safety libonisa ukuba unobungozi obongezelelweyo unokunikezelwa kubantu abaneengxaki zokukhubazeka kwe-bipolar ukuphatha i-akathisia.

Ngokukodwa, i-lipalic beta-blockers efana nepropranolol ifumaneka ukuba isebenza ngokuqhubekayo kunyango lwe-akathisia.

Ukongeza i-benzodiazepines okanye i-amantadine okanye i-clonidine nayo yazama. Ezinye iziyobisi ezisetyenziselwe ukuphatha i-akathisia ziquka ipiracetam, i-ritanserin, i-valproic acid kunye ne-tricyclic antidepressants. Ngoku kutshanje, i-mirtazapine ifumaneke ukuba isebenze i-20-25% yabantu, abanye babo baye bafumana ukuxolelwa ngokupheleleyo kweempawu zabo ze-akathisia.

Umthombo

Miller CH, Fleischhacker WW. Ukulawula i-Antipsychotic-Yenza i-Akathisia enobuchule kunye ne-Chronicle. Ukhuseleko Lweziyobisi 2000 Jan; 22 (1): 73-81.

Praharaj SK, Kongasseri S, Behere RV, Sharma PS. I-Mirtazapine ye-antipsychotic-induced acate akathisia: ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwe-meta-analysis of randbozed controls-controlled controls. Ukuqhubela phambili kweengxaki kwi-Psychopharmacology. 2015 Oct; 5 (5): 307-13.